SCHEMBL8975352

SCHEMBL8975352

CCCn1c(=O)c2[nH]c(-c3ccc(C(=O)N(CC)CC)o3)nc2n(CCC)c1=O

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 14/20 0.55
ADORA2A P29274 7/20 0.55
KDM4E B2RXH2 2/20 0.55
MEN1 O00255 2/20 0.55
ALDH1A1 P00352 2/20 0.55
KMT2A Q03164 2/20 0.55
HSD17B10 Q99714 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
ADORA1 P30542 1/20 0.53
GLA P06280 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8872884 0.87 ADORA2B (0.65) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL8879577 0.77 ADORA2B (0.60) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL8874328 0.74 ADORA2B (0.55) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL8872400 0.73 ADORA2B (0.69) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL7313540 0.72 ADORA2B (0.78) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL8879270 0.72 ADORA2B (0.52) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL7276352 0.72 ADORA2B (0.65) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL1948455 0.72 ADORA2B (1.00) ADORA2BADORA2AKDM4EMEN1ALDH1A1
SCHEMBL1030900 0.71 ADORA2B (0.57) ADORA2BADORA2AADORA1ADORA3
SCHEMBL661108 0.71 ADORA2B (1.00) ADORA2BADORA2AKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5532368-A CHOLINOMIMETIC AGENTS; ALZHEIMER*S DISEASE; CENTRAL NERVOUS SYSTEM DISORDERS BOEHRINGER INGELHEIM GMBH (DE) 1996-07-02 US disclosed
EP-0374808-B1 Xanthin derivatives having an adenosin-antagonist activity BOEHRINGER INGELHEIM KG (DE) 1996-04-17 EP disclosed
US-5175291-A Reaction of 1,4-dioxaspiro 4,4!nonan-7-carboxylic acid with carbonyldiimidazole with 5,6-diamino-1,3-dipropyluracil in the presence of calcium hydroxide and hydroxylating BOEHRINGER INGELHEIM KG (DE) 1992-12-29 US disclosed